Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice
Authors
Keywords
Pharmacokinetics, Neuropathic pain, TRP channels, Mitochondrial sodium calcium exchanger
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 92, Issue 8, Pages 889-900
Publisher
Springer Nature
Online
2014-04-26
DOI
10.1007/s00109-014-1155-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dose-Dependent Adverse Effects of Salinomycin on Male Reproductive Organs and Fertility in Mice
- (2013) Olajumoke Omolara Ojo et al. PLoS One
- Assessment of Paclitaxel Induced Sensory Polyneuropathy with “Catwalk” Automated Gait Analysis in Mice
- (2013) Petra Huehnchen et al. PLoS One
- Effects of salinomycin on human bone marrow-derived mesenchymal stem cells in vitro
- (2013) A. Scherzed et al. TOXICOLOGY LETTERS
- Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2
- (2013) K H Koo et al. Cell Death & Disease
- Salinomycin as a Drug for Targeting Human Cancer Stem Cells
- (2012) Cord Naujokat et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Electrophysiological features of the mouse tail nerves and their changes in chemotherapy induced peripheral neuropathy (CIPN)
- (2012) Massimo Leandri et al. JOURNAL OF NEUROSCIENCE METHODS
- Role of TRPM8 in dorsal root ganglion in nerve injury-induced chronic pain
- (2011) Lin Su et al. BMC NEUROSCIENCE
- A semi-automated method for identifying and measuring myelinated nerve fibers in scanning electron microscope images
- (2011) Heather L. More et al. JOURNAL OF NEUROSCIENCE METHODS
- Comparison of the oral bioavailability and tissue disposition of monensin and salinomycin in chickens and turkeys
- (2011) J. HENRI et al. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS
- Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain
- (2011) Y. Chen et al. NEUROSCIENCE
- Salinomycin induces calpain and cytochrome c-mediated neuronal cell death
- (2011) W Boehmerle et al. Cell Death & Disease
- Identification and quantification of salinomycin in intoxicated human plasma by liquid chromatography–electrospray tandem mass spectrometry
- (2010) Yu Li et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
- (2010) Yong Zhang et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- TRPM8, but not TRPA1, is required for neural and behavioral responses to acute noxious cold temperatures and cold-mimetics in vivo
- (2010) Wendy M. Knowlton et al. PAIN
- Cellular and Molecular Mechanisms of Pain
- (2009) Allan I. Basbaum et al. CELL
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Animal models of chemotherapy-evoked painful peripheral neuropathies
- (2009) Nicolas Authier et al. Neurotherapeutics
- The Contribution of TRPM8 and TRPA1 Channels to Cold Allodynia and Neuropathic Pain
- (2009) Ombretta Caspani et al. PLoS One
- Interaction of Transient Receptor Potential Vanilloid 4, Integrin, and Src Tyrosine Kinase in Mechanical Hyperalgesia
- (2008) N. Alessandri-Haber et al. JOURNAL OF NEUROSCIENCE
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
- A transient receptor potential vanilloid 4 contributes to mechanical allodynia following chronic compression of dorsal root ganglion in rats
- (2007) Yang Zhang et al. NEUROSCIENCE LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now